
Genus plc (GNS.L)
GNS.L Stock Price Chart
Explore Genus plc interactive price chart. Choose custom timeframes to analyze GNS.L price movements and trends.
GNS.L Company Profile
Discover essential business fundamentals and corporate details for Genus plc (GNS.L) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
6 Jul 2000
Employees
3.50K
Website
https://www.genusplc.comCEO
Jorgen Kokke
Description
Genus plc operates as an animal genetics company in North America, Latin America, the United Kingdom, rest of Europe, the Middle East, Russia, Africa, and Asia. The company operates through three segments: Genus PIC, Genus ABS, and Genus Research and Development. It sells sows, boars, and semen to breed pigs with various characteristics for pork production under the PIC brand. The company also sells bull semen and embryos to breed calves with various characteristics for milk and beef production under the ABS, Genus, and Bovec brands. In addition, it offers semen sexing, in reproductive, and other technical services to farmers. Genus plc has a strategic collaboration with Beijing Capital Agribusiness Co. Ltd to pursue the porcine reproductive respiratory syndrome virus resistant regulatory and development work in China. The company was incorporated in 1994 and is based in Basingstoke, the United Kingdom.
GNS.L Financial Timeline
Browse a chronological timeline of Genus plc corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 25 Feb 2026
Upcoming earnings on 3 Sept 2025
Dividend declared on 6 Mar 2025
A dividend of £10.30 per share was announced, adjusted to £10.30. The dividend was paid on 4 Apr 2025.
Earnings released on 27 Feb 2025
EPS came in at £0.02, while revenue for the quarter reached £336.40M.
Dividend declared on 7 Nov 2024
A dividend of £21.70 per share was announced, adjusted to £21.70. The dividend was paid on 6 Dec 2024.
Earnings released on 5 Sept 2024
EPS came in at -£0.08, while revenue for the quarter reached £335.20M, missing expectations by -49.79%.
Earnings released on 30 Apr 2024
EPS came in at £0.20 falling short of the estimated £0.33 by -38.02%, while revenue for the quarter reached £333.60M, missing expectations by -0.71%.
Dividend declared on 29 Feb 2024
A dividend of £10.30 per share was announced, adjusted to £10.30. The dividend was paid on 28 Mar 2024.
Dividend declared on 9 Nov 2023
A dividend of £21.70 per share was announced, adjusted to £21.70. The dividend was paid on 8 Dec 2023.
Earnings released on 7 Sept 2023
EPS came in at £0.30, while revenue for the quarter reached £339.50M, missing expectations by -52.56%.
Earnings released on 23 Feb 2023
EPS came in at £0.20, while revenue for the quarter reached £350.20M.
Dividend declared on 23 Feb 2023
A dividend of £10.30 per share was announced, adjusted to £10.30. The dividend was paid on 30 Mar 2023.
Dividend declared on 8 Sept 2022
A dividend of £21.70 per share was announced, adjusted to £21.70. The dividend was paid on 9 Dec 2022.
Earnings released on 30 Jun 2022
EPS came in at £0.32, while revenue for the quarter reached £312.20M.
Dividend declared on 24 Feb 2022
A dividend of £10.30 per share was announced, adjusted to £10.30. The dividend was paid on 31 Mar 2022.
Earnings released on 31 Dec 2021
EPS came in at £0.30, while revenue for the quarter reached £281.20M.
Dividend declared on 9 Sept 2021
A dividend of £21.70 per share was announced, adjusted to £21.70. The dividend was paid on 10 Dec 2021.
Earnings released on 30 Jun 2021
EPS came in at £0.24, while revenue for the quarter reached £288.60M.
Dividend declared on 25 Feb 2021
A dividend of £10.30 per share was announced, adjusted to £10.30. The dividend was paid on 1 Apr 2021.
Earnings released on 31 Dec 2020
EPS came in at £0.48, while revenue for the quarter reached £285.70M.
Dividend declared on 8 Sept 2020
A dividend of £19.70 per share was announced, adjusted to £19.70. The dividend was paid on 11 Dec 2020.
GNS.L Stock Performance
Access detailed GNS.L performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.